MedTrace Logo

Impact of Combined Psychotherapy and Physiotherapy Group Treatment Program for Survivors of Torture

NCT03470779 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-03-13

No results posted yet for this study

Summary

The aim of this study is to assess the impact and feasibility of an interdisciplinary group treatment approach, involving psychotherapy and physiotherapy, with survivors of torture that are incarcerated in a prison in Kurdistan, Iraq. The primary aim is to develop initial estimates of treatment effects on symptoms and poor functioning consistent with centralized pain and post-traumatic stress disorder, anxiety, and/or depression. The secondary aim is to assess the feasibility of studying this interdisciplinary treatment program in which local Kurdish psychotherapists and physiotherapists provide a 10-week intervention in a prison, in the Kurdish Sorani language, and to Kurdish participants that present with mental health symptoms, physical complaints, and poor functioning

Conditions

  • Pain Syndrome
  • Disability Physical

Interventions

OTHER

Physiotherapy

Treatment group participants will participate in weekly group physiotherapy and psychotherapy sessions as part of the standard program procedure.

OTHER

Psychotherapy

Treatment group participants will participate in weekly group physiotherapy and psychotherapy sessions as part of the standard program procedure.

Sponsors & Collaborators

Principal Investigators

  • Jeff A Hartman, DPT, MPH · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-19
Primary Completion
2018-11-15
Completion
2019-01-01

Countries

  • Iraq

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03470779 on ClinicalTrials.gov